Aktis Oncology Statistics
NASDAQ: AKTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
16.15-0.25 (-1.52%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Aktis Oncology by the numbers
Aktis Oncology has a market capitalization of $901.1 million based on 53.93M shares outstanding. With trailing EPS of $-1.80, Aktis Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.7% below its 50-day average and 21.9% below its 200-day average.
Average daily trading volume is 408.46K shares, or about $6.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AKTS valuation vs. peer median
| Metric | AKTS | Peer median | Difference |
|---|---|---|---|
| Market cap | $901.14M | $940.99M | -4% |
| Avg. volume | 408.46K | 576.70K | -29% |
Peer median across 8 companies: SVRA, MLTX, CYRX, SPTX, LTGO, MTRI, OMER, PHAR.
Valuation
- Market cap
- $901.14M
- EPS (TTM)
- $-1.80
- Shares outstanding
- 53.93M
Price and trading
- Previous close
- 16.40
- Open
- 16.34
- Day range
- 16.00 – 16.74
- 52-week range
- 13.96 – 34.19
- Beta
- —
- Volume
- 374.79K
- Average volume
- 408.46K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 901.14M
- Forward Pe
- -7.15
- Eps
- -1.80
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 34.19
- Week52 Low
- 13.96
- Avg Volume
- 408.46K
- Shares Outstanding
- 53.93M
- Ma50
- 17.70
- Ma200
- 20.67
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -52.76%
- Pct From52w Low
- 15.69%